Press Releases
Samsung Biologics speeds $2B plant build forecast to boost capacity 70%
Samsung Biologics is pushing for early completion of its new $2 billion manufacturing facility in an effort to meet increased demand and boost the South Korean CMO giant’s profits.
All rights are reserved by the media that published this article.
Samsung Biologics is pushing for early completion of its new $2 billion manufacturing facility in an effort to meet increased demand and boost the South Korean CMO giant’s profits.
All rights are reserved by the media that published this article.